Digital Breast Tomosynthesis Market

The Global Digital Breast Tomosynthesis (DBT) Market Industry is projected to experience robust growth over the coming years. With a market value anticipated to reach 6500 USD Million by 2035, the industry is set to expand significantly. The compound annual growth rate of 9.07% from 2025 to 2035 indicates a strong demand for DBT technology as healthcare providers increasingly recognize its benefits. Factors such as rising breast cancer incidence, technological advancements, and government support are likely to drive this growth. The market's trajectory suggests a promising future for DBT, positioning it as a critical component in breast cancer screening and diagnosis.

The rising awareness and education regarding breast cancer screening among women are pivotal in driving the Global Digital Breast Tomosynthesis (DBT) Market Industry. Educational campaigns aimed at informing women about the benefits of early detection and advanced imaging technologies are gaining traction. As more women become aware of the advantages of DBT over traditional mammography, the demand for these services is likely to increase. Healthcare providers are also emphasizing the importance of regular screenings, which further supports market growth. This shift in awareness is anticipated to contribute to the overall expansion of the market, aligning with the projected growth trajectory.

The upward trend in global healthcare expenditure is a significant factor influencing the Global Digital Breast Tomosynthesis (DBT) Market Industry. As countries allocate more resources to healthcare, investments in advanced diagnostic technologies, including DBT, are becoming more prevalent. This increase in spending is driven by the recognition of the importance of early detection in improving breast cancer outcomes. Enhanced funding allows healthcare facilities to upgrade their imaging equipment, thereby increasing the availability of DBT services. As a result, the market is poised for growth, with expectations of reaching a value of 2500 USD Million in 2024 and continuing its upward trajectory.

The increasing prevalence of breast cancer globally serves as a primary driver for the Global Digital Breast Tomosynthesis (DBT) Market Industry. According to health statistics, breast cancer remains one of the most diagnosed cancers among women, prompting a heightened demand for advanced screening technologies. DBT offers improved detection rates compared to traditional mammography, which is crucial in early-stage diagnosis. As the global population ages, the incidence of breast cancer is projected to rise, further fueling the need for effective imaging solutions. This trend is expected to contribute significantly to the market's growth, with projections indicating a market value of 2500 USD Million in 2024.

Government initiatives aimed at improving breast cancer screening and detection are significantly influencing the Global Digital Breast Tomosynthesis (DBT) Market Industry. Many countries are implementing national screening programs that incorporate DBT as a standard practice due to its superior diagnostic capabilities. Increased funding for breast cancer research and awareness campaigns is also driving the adoption of DBT technology. For instance, several governments have allocated substantial budgets to enhance healthcare infrastructure, which includes the procurement of advanced imaging equipment. This supportive regulatory environment is expected to facilitate market growth, contributing to a projected market value of 6500 USD Million by 2035.

Technological innovations in imaging modalities are propelling the Global Digital Breast Tomosynthesis (DBT) Market Industry forward. DBT technology enhances the visualization of breast tissue, allowing radiologists to detect abnormalities with greater accuracy. The integration of artificial intelligence and machine learning into DBT systems is also enhancing diagnostic capabilities, potentially reducing false positives and improving patient outcomes. As healthcare facilities increasingly adopt these advanced technologies, the market is likely to experience substantial growth. The anticipated compound annual growth rate of 9.07% from 2025 to 2035 underscores the significance of these advancements in shaping the future landscape of breast cancer screening.

Based on the Region, the global Digital Breast Tomosynthesis (DBT) are segmented into North America, Europe, Asia-Pacific, South America and Middle East & Africa. The North America dominated the global market in 2024, while the Asia-Pacific is projected to be the fastest–growing segment during the forecast period. Major demand factors driving the North America market are the increasing prevalence of breast cancer and technological advancements and shift toward early and preventive diagnosis. 

The North American tomosynthesis market is expanding rapidly, driven by a number of major factors such as rising breast cancer rates, technological improvements, and increased need for more precise diagnostic techniques. For example, the prevalence of breast cancer in North America is rising. According to the American Cancer Society, approximately one out of every eight women in the United States may acquire breast cancer over their lifetime. 

This has resulted in increased adoption of advanced screening methods, such as tomosynthesis, which improves early detection rates. The increased awareness of breast cancer, combined with updated screening standards, is encouraging healthcare professionals to use digital breast tomosynthesis (DBT) as a tool to improve early diagnosis and eliminate false positives often associated with traditional mammography.

FIGURE 3: DIGITAL BREAST TOMOSYNTHESIS (DBT) MARKET VALUE BY REGION 2024 AND 2035 (USD BILLION)

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Further, the countries considered in the scope of the Application Tracking System Market are the US, Canada, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Brazil, Mexico, Argentina, GCC Countries, South Africa and others.

Many global, regional, and local vendors characterize the Digital Breast Tomosynthesis (DBT) Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.

The major competitors in the market are Hologic, Inc., GE HealthCare, FUJIFILM Holdings Corporation, Trivitron Healthcare Private Limited, Planmed Oy, Siemens Healthineers, PerkinElmer, Canon Medical Systems Corporation, Analogic Corporation, Shimadzu Corporation, NP JSC AMICO, VMI Médica, BEMEMS Co., Ltd., Sino Medical-Device Technology Co., Ltd., Shenzhen Landwind Industry Co., Payamed Electronic Industries Co., Medical Technologies Ltd. (MTL), Metaltronica S.p.A., Lotus Healthcare, Koninklijke Philips N.V., Allengers Medical Systems Ltd., IMS Giotto S.p.A., Shenzhen Angell Technology Co., Ltd., Konica Minolta, Inc., Electron Co. are among others.

The Digital Breast Tomosynthesis (DBT) Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness.